Single-dose pentamidine substantially reduces viability of trypanosomes in human East African trypanosomiasis
Perry J.J. van Genderen, Jan L Nouwen, Mariana de Mendonça Melo, Bart J. A. Rijnders, Jaap J. van Hellemond
Abstract
Open-access reader
Perry J.J. van Genderen, Jan L Nouwen, Mariana de Mendonça Melo, Bart J. A. Rijnders, Jaap J. van Hellemond
Abstract
Open-access reader
Examination of viability of trypomastigotes before and after single-dose pentamidine treatment demonstrated that single-dose pentamidine substantially affected motility of trypomastigotes, a proxy of drug efficacy. This suggests that single-dose pentamidine may be of added value to bridge time until suramin will be available for treatment of human East Africa trypanosomiasis.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Examination of viability of trypomastigotes before and after single-dose pentamidine treatment demonstrated that single-dose pentamidine substantially affected motility of trypomastigotes, a proxy of drug efficacy. This suggests that single-dose pentamidine may be of added value to bridge time until suramin will be available for treatment of human East Africa trypanosomiasis.
Key concepts: Pentamidine, Suramin, African trypanosomiasis, Trypanosomiasis, Medicine, Diminazene, Pharmacology, Virology